2BB score and signals
Opus Genetics, Inc.’s current 2BB score is 12 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 22 | Low |
| Momentum | 32 | Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 60 | Strong |
| Risk | 62 | High |
2BBBullish & Bearish
Opus Genetics, Inc. (IRD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 12 out of 100.
Opus Genetics, Inc.’s current 2BB score is 12 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 22 | Low |
| Momentum | 32 | Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 60 | Strong |
| Risk | 62 | High |
| Founded | 2018 |
| Employees | 28 |
| 52-week range | $1.04 – $5.81 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -0.1515 | — | $2.06M |
| 2026-08-11 | — | -0.1583 | — | $2.49M |
| 2026-05-12 | -0.75 | -0.1439 | $2.16M | $2.96M |
| 2026-03-10 | -0.29 | -0.1175 | $3.87M | $3.37M |